Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharma > B.16 > Flashcards

B.16 Flashcards

1
Q

Progestins and antiprogestins. Contraceptives

A
  1. (pregnans): Medroxyprogesterone-acetate, Drospirenone, Cyproterone-acetate
  2. (estrans): Norethisterone
  3. (gonans): Desogestrel, Levonorgestrel
  4. Progesterone receptor antagonists: Mifepristone, Ulipristal-acetate
  5. Oral contraceptive combination: Ethinylestradiol+Levonorgestrel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contraceptive patches: Estrogen + progestin combinations:

A

Ethinylestradiol (0.6mg) + norelgestronim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contraceptive implants:

A

mplants of norgesterl or etonogestrel (active metabolite of desogestrel)
*DOA: 3-6 years
* low incidence of SEs (low hormonal level): Headache, dizziness, acne, alopecia, mood changes, breast tenderness, decreased libido, weight gain, vasomotor problems, major bleeding disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Local contraceptives

A
  • Intrauterine devices: Levonorgestrel
  • Vaginal ring: Ethinylestradiol and etonorgestrel released every day
  • Spermicidal disinfectants: Benzalkonium, nonoxinol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hormonal contraception

A
  1. Oral contraception
  2. Parenteral (depot) contraception
  3. Transdermal contraceptives
  4. Contraceptive implants
  5. Local contraceptives
  6. Postcoital contraceptives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Morning after pill

A
  • Progestin alone or in combination with estrogen (combo has no beneficial effect over monotherapy)
    • within 72h after coitus (best within 12h)
    • high dose levonorgestrel
    • Common SEs: nausea, vomiting, headache, dizziness, breast tenderness, abdominal and leg cramps
  • Ulipristal-acetate
    • SPRM, within 5 days (best earlier)
    • SEs: similar to progestins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Abortion pill

A

Mifepristone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Oral Contraceptives

A
  1. Estrogen + progestin combination
  2. Progestins alone (minipill)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. Estrogen + progestin combination
A
  • Monophasic:
    Estrogen component: Ethinylestradiol (0.02-0.035mg)
    Progestin component: Levonorgestrel (0.1-0.25mg), Norgestimate (0.25), Desogestrel (0.15mg), Gestodene (0.075mg), Chlormadinone (1.71mg), Drospirenone (3mg)
  • Biphasic: days 1-10, 11-21
    Ethinylestradiol (0.03-0.05mg) + Levonorgestrel (0.05→0.125mg) or Desogestrel (0.025→0.125mg)

-Triphasic: e.g. days 1-7, 8-14, 15-21
Ethinylestradiol (0.03→0.04→0.03mg) + gestoden (0.05→0.07→0.1mg) or Levonorgestrel (0.05→0.075→0.125mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Effects of oral contraceptives (estrogens+progestins) on sexual organs

A
  • Contraceptive MOA: inhibition of pituitary function, inhibition of ovulation, changes in cervical mucus, endometrium, motility, secretion
  • Chronic use depresses ovarian function, and the ovary becomes smaller
  • Uterus: Cervix hypertrophy (polyp formation), thicker and less copious cervical mucus, preparations containing 19-norsteroids→ Glandular atrophy less bleeding
  • Breast: Enlargement, Suppression of lactation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side effects of oral contraceptive (estrogen+progestin)

A

Advantageous SEs:
- Lower incidence of ovarian and endometrial cancer, ovarian cysts
- Less bleeding, lower incidence of anemias
- Improvement of endometriosis, dysmenorrhea
Disadvantageous SEs:
Mild adverse effects→ nausea, edema, mastalgia, endocrine changes, headache, loss of withdrawal bleeding
Moderate adverse effects→ breakthrough bleeding, weight gain, skin pigmentation, acnes, hirsutism, uteral dilation, vaginal infections, amenorrhea
Severe adverse effects→ increased risk of vascular disorders (venous thromboembolism, MI, cerebrovascular disease), Increased risk of GI disorders (cholestasis, gallbladder disease, hepatic adenomas), mental depression, cervical and breast cancer::Mild, Moderate, Severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contra-IND of oral contraceptives

A
  • Thrombormbolism, cerebrovascular disorders
  • Estrogen-dependent neoplasm
  • Vaginal bleeding with unknown origin
  • Before the epiphyseal closure is complete
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Progestins alone (minipill):
A
  • Daily progestin tablet: Norethindrone (0.35mg) / norgestrel(0.075mg)
  • useful in patients for whom estrogens are undesired or contra-IND (e.g. hepatic disease, prior thromboembolism)
  • SEs: Headache, dizziness, weight gain, impaired glucose tolerance, abnormal bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Parenteral (depot) contraceptives

A
  • Injection of depot medroxyprogesterone-acetate (150mg i.m) every 2-3months
    *common SEs: Headache, impaired glucose tolerance, disadvantageous lipid change, abnormal bleeding
  • Can also be injection of combination estrogen+progestin (same as the oral ones)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Postmenopausal hormonal therapy

A

Therapeutic goal:
- Symptomatic relief of atrophic vaginitis and other local problems by local use of estrogens
- Symptomatic relief of hotflashes, sweating, insomnia, climecteric psychopathologic states (mental depression) with a short-term hormonal therapy
- long term prevention and treatment of osteoporosis
Estrogens alone relieve the symptoms, but in case of systemic use and intact uterus progestins are added to reduce the risk of endometrial cancer

Adverse effect:
- Local and short term treatment: less problematic
- Chronic systemic postmenopausal hormone replacement increases the risk of the cardiovascular complications and breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

IND of progestins

A

-Primary hypogonadism (→hormone replacement therapy, combined with estrogens)
-Postmenopausal hormone therapy (to reduce the risk of endometrial cancer caused by estrogens)
-Hormonal contraception:
Long-term ovarian suppression (treatment of dysmenorrhea, endometriosis, bleeding disorders when estrogens are Contra-IND)
-Prevention of preterm birth(?)
-Palliative treatment of estrogen-dependent tumors
SEs of progestins: increased risk of breast cc; ↓HDL; Impairment of glucose tolerance; Elevation of BP; Headache, psychic disturbances; Androgenic/anabolic adverse effects of 19-norsteroids; abnormal bleeding

17
Q

Medroxyprogesterone-acetate

A

MOA: Synthetic progestin, Pregnans, closely related to progesterone;
IND: prevent menstruation (but doesn’t arrest bone maturation in children with preterm puberty), p.e (depot) contraceptive, Recurrent/metastatic breast cc (in post menopausal), recurrent/metastatic endometrial cc, recurrent/metastatic renal cc;
Kinetics: can be injected in depot (150mg i.m every 2-3months);
SEs: heat waves, ↓libido, erectile dysfunction, glucocorticoid-like effects, thrombophilia, osteoporosis, edema, hypercalcemia

18
Q

Drospirenone, Cyproterone-acetate

A

MOA: Synthetic progestin, Pregnans, closely related to progesterone;
Kinetics: Drospirenone→oral contraceptive, monophasic, combined with Ethinylestradiol (estrogen);
IND: Cyproterone-acetate- inoperable prostate cc;
SEs: thromboembolism, osteoporosis, erectile dysfunction, ↓libido, heat waves

19
Q

Norethisterone

A

MOA: Synthetic progestin, Estrans, androgen/anabolic action (do NOT support pregnancy, produce non-physiologic changes of endometrium, inhibit implantation);
IND: Oral contraceptive;
Kinetics: p.o, daily (useful in patients for whom estrogens are undesired or contra-IND (e.g. hepatic disease, prior thromboembolism)

20
Q

Levonorgestrel, Desogestrel

A

MOA: Synthetic progestin, Gonans;
IND: oral contraceptive (in combination with estrogen), levonorgestrel (→”morning after” pill), desogestrel (→s.c. contraceptive implants);
Kinetics: p.o adm. in combination with ethinylestradiol, can be monophasic, biphasic (days 1-10, 11-21) or triphasic-only Levonorgestrel (e.g. days 1-7, 8-14, 15-21). Desogestrel s.c. contraceptive implant (DOA: 3-6 years)

21
Q

Ethinylestradiol + Levonorgestrel

A

IND: Oral/local contraceptive Kinetics: p.o adm. in combination with ethinylestradiol, can be monophasic, biphasic (days 1-10, 11-21) or triphasic (e.g. days 1-7, 8-14, 15-21).
Can be local contraceptive use-IUD (→DOA: 5 years, daily 20μg release, low systemic hormone levels)

22
Q

Mifepristone

A

MOA: 19-norsteroid, progesterone-R antagonist, has antiglucocorticoid activity;
IND: Abortion-pregnancy termination (in combination with vaginal PGE1 or with its analog misoprostol p.o), endometriosis, breast cancer, meningeoma;
SEs: of the combination(→vomiting, diarrhea, abdominal pain, vaginal bleeding)

23
Q

Ulipristal acetate

A

MOA: SPRM (progesterone R antagonist);
IND: morning after pill (within 5 days, best earlier), treatment of myomas;
SEs: similar to progestins

24
Q

SPRM

A

19-Nor-steroid, progesterone receptor antagonist

25
Q

Monophasic pills

A

contain a fixed dose of the same hormones (either estrogen&progestin or just progestin) in each active pill.

26
Q

Biphasic pills

A

contain 2 different doses of hormones in each active pill

27
Q

Triphasic pills

A

contain 3 different doses of hormones in each active pill

28
Q

Palliative treatment

A

a treatment that makes the patient feel more comfortable but doen’t cure the cancer.

29
Q

The progestins

A
  • Natural progestin: Progesterone, produced by Corpus luteum
  • Orally ineffective (first pass metabolism) → i.m administration
  • Physiologic effects (intracellular receptors → gene expression)
    • main action: inhibit proliferation, promote differentiation
      • Endometrium: maturation and secretory changes following ovulation
      • Breast: proliferation→ then alveolobular development of the secretory apparatus
      • Implantation, maintenance of pregnancy, inhibition of ovulation
      • Increase of body temperature
      • Metabolic effects: Fat deposition, effects of carbohydrates metabolism, ketogenesis
      • Competition with aldosterone receptor → decreased Na reabsorption
      • Respiratory effect: ventilatory response to CO2 is increased
      • Depressant and hypnotic/sedative effects on the brain
      • Increased urinary Nitrogen excretion

Pharma (86 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions